Literature DB >> 11897614

First description of a TEM-30 (IRT-2)-producing Klebsiella oxytoca isolate.

Sophie A Granier, Jean-Claude Nguyen Van, Marie-Dominique Kitzis, Fred W Goldstein, Véronique Leflon-Guibout, Marie-Hélène Nicolas-Chanoine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11897614      PMCID： PMC127080          DOI： 10.1128/AAC.46.4.1158-1159.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  Updated sequence information and proposed nomenclature for bla(TEM) genes and their promoters.

Authors:  V Leflon-Guibout; B Heym; M Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates.

Authors:  E Hadziyannis; M Tuohy; L Thomas; G W Procop; J A Washington; G S Hall
Journal:  Diagn Microbiol Infect Dis       Date:  2000-02       Impact factor: 2.803

3.  Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR.

Authors:  V Speldooren; B Heym; R Labia; M H Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Phylogeny of mercury resistance (mer) operons of gram-negative bacteria isolated from the fecal flora of primates.

Authors:  C A Liebert; J Wireman; T Smith; A O Summers
Journal:  Appl Environ Microbiol       Date:  1997-03       Impact factor: 4.792

5.  Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytoca.

Authors:  H Bermudes; F Jude; E B Chaibi; C Arpin; C Bebear; R Labia; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

6.  Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca.

Authors:  B Fournier; C Y Lu; P H Lagrange; R Krishnamoorthy; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Incompatibility groups and the classification of fi - resistance factors.

Authors:  Y A Chabbert; M R Scavizzi; J L Witchitz; G R Gerbaud; D H Bouanchaud
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

8.  Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.

Authors:  D Sirot; R Labia; P Pouedras; C Chanal-Claris; C Cerceau; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

9.  Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2.

Authors:  B Fournier; P H Roy; P H Lagrange; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

10.  A survey of beta-lactamases from 618 isolates of Klebsiella spp.

Authors:  R Reig; C Roy; M Hermida; D Teruel; A Coira
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790
  10 in total
  2 in total

1.  Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period.

Authors:  Elisenda Miró; Ferran Navarro; Beatriz Mirelis; Montserrat Sabaté; Alba Rivera; Pere Coll; Guillem Prats
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

2.  Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.

Authors:  Jing Yang; Haiyan Long; Ya Hu; Yu Feng; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2021-12-01       Impact factor: 50.129
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.